More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Strengthens Europe Leadership Team With Appointment of Alex Grapov As International Vice President

Medical Marijuana, Inc. Strengthens Europe Leadership Team With Appointment of Alex Grapov As International Vice President

by adminAdrianRamirez | May 22, 2017 | Kannaway, Press Releases

[vc_row][vc_column][vc_column_text] SAN DIEGO, May 22, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that it has appointed Alex Grapov as its International Vice President. Grapov’s first priority will be to open Medical Marijuana Inc....
Medical Marijuana, Inc. Subsidiary Kannaway® Announces IGNITE! National Convention 2017 in Scottsdale, AZ

Medical Marijuana, Inc. Subsidiary Kannaway® Announces IGNITE! National Convention 2017 in Scottsdale, AZ

by adminAdrianRamirez | May 18, 2017 | Kannaway, Press Releases

Company to Celebrate 11X Growth, Announce New Product Line, and Celebrate Brand Ambassador Achievements at Event SAN DIEGO, May 18, 2017  — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary Kannaway LLC, the first hemp lifestyle network to...
Medical Marijuana, Inc. CEO Dr. Stuart Titus Talks Science of Cannabinoids with YEW Media

Medical Marijuana, Inc. CEO Dr. Stuart Titus Talks Science of Cannabinoids with YEW Media

by adminAdrianRamirez | May 17, 2017 | Company News, Media Coverage

[vc_row][vc_column][vc_column_text] Dr. Stuart Titus appeared on podcast Yew Media yesterday to discuss cannabinoid research and share the many successes that Medical Marijuana, Inc. has achieved in recent months. Radio personality Chris Cantore recently invited...
SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00

SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00

by adminAdrianRamirez | May 17, 2017 | Axim Biotechnologies, Canchew, Press Releases

SAN DIEGO, May 17, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) received coverage...
AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov

AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov

by adminAdrianRamirez | May 16, 2017 | Axim Biotechnologies, Press Releases

NEW YORK, May 15, 2017 –– AXIM® Biotechnologies, Inc. (AXIM® Biotech) AXIM, +37.64% a world leader in cannabinoid research and development, today announced that information on the company’s Bioavailability Study on Dronabinol in a controlled-release, functional...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.